A detailed history of Black Rock Inc. transactions in X Biotech Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,134,146 shares of XBIT stock, worth $7.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,134,146
Previous 306,624 269.88%
Holding current value
$7.24 Million
Previous $2.49 Million 133.91%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.54 - $9.89 $3.76 Million - $8.18 Million
827,522 Added 269.88%
1,134,146 $5.83 Million
Q1 2024

May 10, 2024

BUY
$4.03 - $8.13 $114,713 - $231,420
28,465 Added 10.23%
306,624 $2.49 Million
Q4 2023

Feb 13, 2024

SELL
$3.56 - $4.65 $2,406 - $3,143
-676 Reduced 0.24%
278,159 $1.11 Million
Q3 2023

Nov 13, 2023

SELL
$4.02 - $5.81 $44,268 - $63,979
-11,012 Reduced 3.8%
278,835 $1.15 Million
Q2 2023

Aug 11, 2023

BUY
$3.06 - $6.38 $84,612 - $176,413
27,651 Added 10.55%
289,847 $1.72 Million
Q1 2023

May 12, 2023

BUY
$3.22 - $4.72 $3,203 - $4,696
995 Added 0.38%
262,196 $904,000
Q4 2022

Feb 13, 2023

BUY
$3.03 - $3.79 $6,869 - $8,591
2,267 Added 0.88%
261,201 $916,000
Q3 2022

Nov 14, 2022

BUY
$3.58 - $5.88 $14,327 - $23,531
4,002 Added 1.57%
258,934 $938,000
Q2 2022

Aug 12, 2022

SELL
$5.13 - $9.2 $3.97 Million - $7.12 Million
-774,178 Reduced 75.23%
254,932 $1.44 Million
Q1 2022

May 12, 2022

SELL
$8.64 - $11.71 $230,394 - $312,258
-26,666 Reduced 2.53%
1,029,110 $8.89 Million
Q4 2021

Feb 10, 2022

SELL
$10.95 - $16.07 $1.84 Million - $2.7 Million
-167,878 Reduced 13.72%
1,055,776 $11.8 Million
Q3 2021

Nov 09, 2021

BUY
$12.95 - $18.24 $285,638 - $402,319
22,057 Added 1.84%
1,223,654 $15.8 Million
Q2 2021

Aug 11, 2021

BUY
$15.83 - $17.84 $19 Million - $21.4 Million
1,201,597 New
1,201,597 $19.9 Million

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $194M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.